Oral Isotretinoin in the Treatment of Postoperative Edema in Thick-Skinned Rhinoplasty: A Randomized Placebo-Controlled Clinical Trial
- 131 Downloads
The thick-skinned nose is still one of the most challenging aspects of rhinoplasty. The possible effects of oral isotretinoin on cosmetic results of rhinoplasty in patients with thick nasal skin have been considered during recent years.
In this double-blind placebo-controlled clinical trial, 48 cases were divided into two groups randomly. Oral isotretinoin (0.5-mg/kg) was started on the 31st day after surgery and given every other day for 1 month and after that daily for two additional months in the first group. The second group received a placebo in the same form, sequence and interval as the first group. The cosmetic results based on patient satisfaction and ranking by an expert surgeon were compared between the two groups at 3 months, 6 months and 1 year after surgery.
Patient satisfaction and ranking by an expert surgeon in the isotretinoin group at 3 months and 6 months after surgery were significantly better than in the placebo group (p value < 0.05); however, at 12 months after surgery there was no statistically significant difference between the two groups (p value > 0.05).
Though postoperative use of oral isotretinoin in patients with thick nasal skin accelerates improvement in cosmetic results during the early months after surgery, it does not significantly affect the final cosmetic result 1 year after surgery.
Level of Evidence II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
KeywordsRhinoplasty Oral Isotretinoin Postoperative edema Thick skin
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest to disclose.
- 4.Sadeghi M, Saedi B, Safavi A, Iri MR (2012) Postrhinoplasty acne formation: a case–control study. B-ENT 9:95–100Google Scholar
- 5.Beckenbach L, Baron JM, Merk HF, Löffler H, Amann PM (2015) Retinoid treatment of skin diseases. Eur J Dermatol 25:384–391Google Scholar
- 6.Fox LP, Merk HF, Bickers DR (2006) Dermatopharmakologie. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman & Gilman’s—Pharmakologische Grundlagen der Arzneimitteltherapie. ABW Wissenschaftsverlag GmbH, Berlin, pp 1–73Google Scholar
- 15.Roberts WE (2008) The Roberts skin type classification system. J Drugs Dermatol 7:452–456Google Scholar